Aims: To compare and correlate retinal nerve fiber layer (RNFL) measurements obtained by scanning laser polarimetry (SLP) with defects detected by short-wavelength automatic perimetry (SWAP) in eyes with ocular hypertension (OHT). Methods: SLP and SWAP were performed in 96 eyes of 48 consecutive patients with OHT. Results: Twenty-five eyes (26%) had SWAP visual field defects. Twenty-seven eyes (28.1%) had abnormal RNFL evaluation defined by the GDx neural network (‘number’ >29). Fourteen eyes of 10 patients (14.5%) had abnormal RNFL evaluation and SWAP visual field defects. RNFL thickness measurements were significantly reduced in eyes with abnormal SWAP. A weak but statistically significant correlation between the ‘number’ and pattern standard deviation (r = 0.3, p = 0.006) and the corrected pattern standard deviation (r = 0.3, p = 0.007) in SWAP was found. Areas of abnormal RNFL thickness corresponded to the localization of the SWAP visual field defects in corrected pattern deviation plots in 10 of the 14 eyes with defects in both tests. Conclusions: SWAP visual field defects frequently coexist and correspond with abnormalities of RNFL detected by SLP in eyes with OHT. In certain eyes, however, the two methods detect different glaucoma properties.

1.
Hollows FC, Graham PA: Intraocular pressure, glaucoma, and glaucoma suspects in defined population. Br J Ophthalmol 1966;50:570–586.
2.
Leibowitz HM, Krueger DE, Maunder LR, Milton RC, Kini MM, Kahn HA, Nickerson RJ, et al: The Framingham Eye Study. Surv Ophthalmol 1980;24(suppl):335–610.
3.
Sommer A, Tielsch JM, Katz J, Quigley HA, Gottsch JD, Javitt J, Singh K: Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans. The Baltimore Eye Survey. Arch Ophthalmol 1991;109:1090–1095.
4.
Klein BE, Klein R, Sponsel WE, Franke T, Cantor LB, Martone J, Menage MJ: Prevalence of glaucoma. The Beaver Dam Eye Study. Ophthalmology 1992;99:1499–1504.
5.
Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, et al: The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 2002;120:701–713.
6.
Quigley HA, Enger C, Katz J, Sommer A, Scott R, Gilbert D: Risk factors for the development of glaucomatous visual field loss in ocular hypertension. Arch Ophthalmol 1994;112:644–649.
7.
Wilson RM, Martone JF: The epidemiology of chronic open angle glaucoma and ocular hypertension; in Ritch R, Shields MB, Krupin T (eds): The Glaucomas. St Louis, Mosby-Year Book, 1996, vol 1, chap 28, pp 753–758.
8.
Georgopoulos G, Andreanos D, Liokis N, Papakonstantinou D, Vergados J, Theodossiadis G: Risk factors in ocular hypertension. Eur J Ophthalmol 1997;7:357–363.
9.
Johnson CA, Brand JD, Khong AM, Adams AJ: Short-wave-length automated perimetry in low-, medium-, and high-risk ocular hypertensive eyes: initial baseline results. Arch Ophthalmol 1995;113:70–76
10.
Lauande-Pimentel R, Carvalho RA, Oliveira HC, Goncalves DC, Silva LM, Costa VP: Discrimination between normal and glaucomatous eyes with visual field and scanning laser polarimetry measurements. Br J Ophthalmol 2001;85:586–591.
11.
Horn FK, Nguyen NX, Mardin CY, Junemann AG: Combined use of frequency doubling perimetry and polarimetric measurements of retinal nerve fiber layer in glaucoma detection. Am J Ophthalmol 2003;135:160–168.
12.
Sommer A, Katz J, Quigley HA, Miller NR, Robin AL, Richter RC, Witt KA: Clinically detectable nerve fiber atrophy precedes the onset of glaucomatous field loss. Arch Ophthalmol 1991;109:77–83.
13.
Teesalu P, Airaksinen J, Tuulonen A: Blue-on-yellow visual field and retinal nerve fiber layer in ocular hypertension and glaucoma. Ophthalmology 1998;105:2077–2081.
14.
Polo V, Abecia E, Pablo LE, Pinilla I, Larrosa JM, Honrubia FM: Short-wavelength automated perimetry and retinal nerve fiber layer evaluation in suspected cases of glaucoma. Arch Ophthalmol 1998;116:1295–1298.
15.
Sanchez-Galeana CA, Bowd C, Zangwill LM, Sample PA, Weinreb RN: Short-wavelength automated perimetry results are correlated with optical coherence tomography retinal nerve fiber layer thickness measurements in glaucomatous eyes. Ophthalmology 2004;111:1866–1872.
16.
Polo V, Larrosa JM, Pinilla I, Perez S, Gonzalvo F, Honrubia FM: Predictive value of short-wavelength automated perimetry: a 3-year follow-up study. Ophthalmology 2002;109:761–765.
17.
Airaksinen J, Tuulonen A, Werner E: Clinical evaluation of the optic disc and retinal nerve fiber layer; in Ritch R, Shields MB, Krupin T (eds): The Glaucomas. St Louis, Mosby-Year Book, 1996, vol 1, chap 28, pp 617–657.
18.
Weinreb RN, Shakiba S, Zangwill L: Scanning laser polarimetry to measure the nerve fiber layer of normal and glaucomatous eyes. Am J Ophthalmol 1995;119:627–636.
19.
Hollfi G, Süveges I, Nagymihály A: Scanning laser polarimetry of the retinal nerve fibre layer in primary open angle and capsular glaucoma. Br J Ophthalmol 1997;81:857–861.
20.
Weinreb RN, Zangwill L, Berry CC, Bathija R, Sample P: Detection of glaucoma with scanning laser polarimetry. Arch Ophthalmol 1998;116:1583–1589.
21.
Hoh ST, Ishikawa H, Greenfield DS, Liebmann JM, Chew SJ, Ritch R: Peripapillary nerve fiber layer thickness measurement reproducibility using scanning laser polarimetry. J Glaucoma 1998;7:12–15.
22.
Kook MS, Sung K, Park RH, Kim KR, Kim ST, Kang W: Reproducibility of scanning laser polarimetry (GDx) of peripapillary retinal nerve fiber layer thickness in normal subjects. Graefes Arch Clin Exp Ophthalmol 2001;239:118–121.
23.
Choplin NT, Lundy DC: The sensitivity and specificity of scanning laser polarimetry in the detection of glaucoma in a clinical setting. Ophthalmology 2001;108:899–904.
24.
Poinoosawmy D, Tan JC, Bunce C, Membrey LW, Hitchings RA: Longitudinal nerve fibre layer thickness change in normal-pressure glaucoma. Graefes Arch Clin Exp Ophthalmol 2000;238:965–969.
25.
Hollfi G, Szabó A, Vargha P: Scanning laser polarimetry versus frequency doubling perimetry and conventional threshold perimetry: changes during a 12 month follow-up in preperimetric glaucoma. Acta Ophthalmol Scand 2001;79:403–407.
26.
Mok KH, Lee WV: Nerve fiber analyzer and short-wavelength automated perimetry in glaucoma suspects: a pilot study. Ophthalmology 2000;107:2101–2104.
27.
Mok KH, Lee WV, So KF: Retinal nerve fiber layer measurement by optical coherence tomography in glaucoma suspects with short-wavelength perimetry abnormalities. J Glaucoma 2003;12:45–49.
28.
Choplin NT, Lundy DC, Dreher AW: Differentiating patients with glaucoma from glaucoma suspects and normal subjects by nerve fiber layer assessment with scanning laser polarimetry. Ophthalmology 1998;105:2068–2076.
29.
GDxTM System Manual. San Diego, Laser Diagnostic Technologies.
30.
Trible J, Schultz RO, Robinson JC, Rothe TL: Accuracy of scanning laser polarimetry in the diagnosis of glaucoma. Arch Ophthalmol 1999;117:1298–1304.
31.
Poinoosawmy D, Tan JC, Bruce C, Hitchings RA: The ability of GDx nerve fiber analyser neural network to diagnose glaucoma. Graefes Arch Clin Exp Ophthalmol 2001;239:122–127.
32.
Lauande-Pimentel R, Carvalho RA, Oliveira HC, Goncalves DC, Silva LM, Costa VP: Discrimination between normal and glaucomatous eyes with visual field and scanning laser polarimetry measurements. Br J Ophthalmol 2001;85:586–591.
33.
Paczka JA, Friedman DS, Quigley HA, Barron Y, Vitale S: Diagnostic capabilities of frequency-doubling technology, scanning laser polarimetry, and nerve fiber layer photographs to distinguish glaucomatous damage. Am J Ophthalmol 2001;131:188–197.
34.
Nguyen NX, Horn FK, Hayler J, Wakili N, Junemann A, Mardin CY: Retinal nerve fiber layer measurements using laser scanning polarimetry in different stages of glaucomatous optic nerve damage. Graefes Arch Clin Exp Ophthalmol 2002;240:608–614.
35.
Airaksinen PJ, Drance SM, Douglas GR, Schulzer M, Wijsman K: Visual field and retinal nerve fiber layer comparisons in glaucoma. Arch Ophthalmol 1985;103:205–207.
36.
Quigley HA, Reacher M, Katz J, Strahlman E: Quantitative grading of nerve fiber layer photographs. Ophthalmology 1993;100:1800–1807.
37.
Kanamori A, Nakamura M, Escano MF, Seya R, Maeda H, Negi A: Evaluation of the glaucomatous damage on retinal nerve fiber layer thickness measured by optical coherence tomography. Am J Ophthalmol 2003;135:513–520.
38.
Ugurlu S, Hoffman D, Garway-Heath D, Caprioli J: Relationship between structural abnormalities and short-wavelength perimetric defects in eyes at risk for glaucoma. Am J Ophthalmol 2000;129:592–598.
39.
Susanna JR, Galvao-Filho RP: Study of the contralateral eye in patients with glaucoma and a unilateral perimetric defect. J Glaucoma 2000;9:34–37.
40.
Reus NJ, Colen TP, Lemij HG: Visualization of localized retinal nerve fiber layer defects with the GDx with individualized and with fixed corneal compensation of anterior segment birefringence. Ophthalmology 2003;110:1512–1516.
41.
Choplin NT, Zhou Q, Knighton RW: Effect of individualized compensation for anterior segment birefringence on retinal nerve fiber layer assessments as determined by scanning laser polarimetry. Ophthalmology 2003;110:719–725.
42.
Kook MS, Cho HS, Seong M, Choi J: Scanning laser polarimetry using variable corneal compensation in the detection of glaucoma with localized visual field defects. Ophthalmology 2005;112:1970–1978.
43.
Colen TP, Lemij HG: Sensitivity and specificity of the GDx: clinical judgment of standard printouts versus the number. J Glaucoma 2003;12:129–133.
44.
Essok EA, Sinai MJ, Bowd C, et al: Fourier analysis of optical coherence tomography and scanning laser polarimetry retinal nerve fiber layer measurements in the diagnosis of glaucoma. Arch Ophthalmol 2003;121:1238–1245.
45.
Gordon MO, Beiser JA, Brandt JD, Heuer DK, Higginbotham EJ, Johnson CA, et al: The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol 2002;120:714–720.
46.
Mohammadi K, Bowd C, Weinreb R, Medeiros F, Sample P, Zangwill L: Retinal nerve fiber layer thickness measurements with scanning laser polarimetry predict glaucomatous visual field loss. Am J Ophthalmol 2004;138:592–601.
47.
Bowd C, Zangwill LM, Weinrieb RN: Association between scanning laser polarimetry measurements using variable corneal polarization compensation and visual field sensitivity in glaucomatous eyes. Arch Ophthalmol 2003;121:961–966.
48.
Reus NJ, Lemij HG: The relationship between standard automated perimetry and GDx VCC measurements. Invest Ophthalmol Vis Sci 2004;45:840–845.
49.
Schlottmann PG, Cilla SD, Greenfield DS, Caprioli G, Garway-Heath DF: Relationship between visual field sensitivity and retinal nerve fiber layer thickness as measured by scanning laser polarimetry. Invest Ophthalmol Vis Sci 2004;45:1823–1829.
50.
Greenfield DS, Knighton RW, Feuer WJ, Schiffman JC, Zangwill L, Weinreb RN: Correction for corneal polarization axis improves the discriminating power of scanning laser polarimetry. Am J Ophthalmol 2002;134:27–33.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.